Despite an increase in operating profit and a surge in operating cash flow to a record ¥14.4 billion, net income was halved year-over-year. Furthermore, the company announced a plan that significantly falls short of the ¥9.0 billion operating profit target set in its mid-term management plan.
If you only look at the surface numbers, it might seem like their core business is stalling. However, unpacking the financial statements and segment data reveals a completely different landscape. The company’s earning power hasn’t decayed; rather, it is in the midst of a drastic structural reform—shedding its low-profit legacy businesses to concentrate resources on high-purity electronic materials for AI servers and electric vehicles.
In this article, we analyze the financial data of Sakai Chemical Industry (4078), a long-established chemical manufacturer that just cleared out its dead weight with a massive ¥3.0 billion impairment loss. From a value investor’s perspective, we will examine the downside resilience provided by its net cash—equivalent to roughly 47% of its market capitalization—and its transition scenario into a highly profitable enterprise.
Withdrawing from Legacy Operations and Shifting to High-Purity Materials
Founded in 1918 as an inorganic and organic chemical manufacturer, Sakai Chemical Industry’s current primary profit driver is no longer its traditional commodity chemicals.
The source of its competitive edge lies in advanced powder processing and organic synthesis technologies. In particular, its hydrothermal synthesis method for producing ultra-small, uniform barium titanate powder has built an extremely high barrier to entry (wide moat). This material is essential for high-capacity MLCCs (Multilayer Ceramic Capacitors) used in cutting-edge AI servers and EVs. In fact, this electronic materials segment now boasts a profit margin exceeding 20%, growing into the main pillar driving the company’s overall operating profit.
Conversely, the pigment-grade titanium dioxide business, a commodity product, had fallen into low profitability due to intensifying competition with cheap imports, primarily from China. The company decisively withdrew from this legacy business in the fiscal year ending March 2026. Furthermore, it recorded an impairment loss of approximately ¥3.0 billion on fixed assets, including a new multi-plant for cosmetic materials (inorganic UV scatterers), due to a deteriorating demand environment.
The halved net income was primarily caused by this one-time impairment charge, not an operational deficit draining cash. Instead, it should be evaluated positively as a move to clean up unprofitable products and front-load the reduction of future fixed cost burdens.
Profitability and Cash Generation Trends
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue (¥bn) | 82.11 | 84.41 | 81.45 |
| Net income (¥bn) | -7.09 | 5.01 | 2.75 |
| Net profit margin | -8.6% | 5.9% | 3.4% |
Although revenue is trending downward, partly due to the withdrawal from the titanium dioxide business, what deserves attention is the core business’s ability to generate cash.
In the fiscal year ending March 2026, while net income dropped to ¥2.75 billion, operating cash flow surged significantly year-over-year to ¥14.48 billion. This was achieved by compressing inventory and strictly collecting trade receivables (shortening the cash conversion cycle). The company is successfully transitioning to a structure where the revenue drop of roughly ¥10.0 billion from the withdrawal is bottom-supported by increased revenue and profit in electronic materials (up 21.7% year-over-year).
The Gap Between Owner Earnings and Valuation
(* Simulation assumptions: estimated share price 3,955 yen, required return 5%)
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| Owner earnings (¥bn) | -7.17 | 0.73 | 0.76 |
| Owner earnings value (¥bn) | -143.46 | 14.66 | 15.22 |
While superficial net income has significantly diminished due to the impairment, owner earnings have maintained the previous year’s level. The company is generating enough leeway through strong operating cash flow, even while executing capital expenditures (¥5.73 billion) that exceed depreciation and amortization expenses (¥3.74 billion).
However, the owner earnings value based on the simulation (approximately ¥15.2 billion) is substantially lower than the current estimated market capitalization (approximately ¥60.5 billion). This gap indicates that the overall earning power (especially the sluggishness in cosmetic materials and medical businesses) is still offsetting the growth in electronic materials. To justify the current stock price level, it is essential for the now-leaner businesses to turn profitable and for electronic materials to expand further.
Downside Resilience Supported by Ample Cash
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| Net cash (¥bn) | 28.90 | 29.14 | 28.29 |
| Net current asset ratio | 45.1% | 45.4% | 46.7% |
What value investors cannot overlook is the robust balance sheet.
The company holds approximately ¥28.3 billion in net cash, which equates to about 47% of its estimated market capitalization. The equity ratio is also high at 66.3%, indicating an extremely solid financial safety net.
Backed by this abundant financial leeway, the company significantly repaid borrowings while executing a ¥2.5 billion stock buyback (all repurchased shares have been retired). For the fiscal year ending March 2027, the company has committed to a dividend policy targeting a DOE (Dividend on Equity) of over 3% (planning ¥160 per share), which is expected to function as a solid downside support for the stock price.
Risks Accompanying the Business Transition
When considering an investment, the following risks must be factored in:
- Structural stagnation in the cosmetic materials business: The shift toward inorganic UV scatterers has been slower than expected, creating a risk that early profitability may remain elusive even after the impairment.
- Missed mid-term targets and fixed cost burdens: If the growth of other businesses fails to cover the revenue shrinkage after withdrawing from titanium dioxide, the fixed cost burden will weigh heavily.
- Surging raw material prices: There are concerns that rising procurement costs for solvents and resin raw materials, driven by geopolitical tensions in the Middle East, could compress profit margins.
Wait-and-See While Monitoring the Structural Shift
In conclusion, I evaluate Sakai Chemical Industry as being at a stage where “downside resilience is extremely high, but the transition process toward high profitability needs careful observation.”
Having completed the “cleanup” through the divestiture of unprofitable businesses and a massive impairment, the company has limited downside risk, backed by net cash covering nearly half its market cap and a strong shareholder return stance (DOE > 3%). However, if the sluggishness in the cosmetic and medical businesses—the culprits behind the missed mid-term targets—persists, upside potential is also expected to be heavy.
Therefore, while I will pass on an immediate buy at this moment, I will turn bullish if the following conditions are met.
[Triggers to consider buying]
- If quarterly financial results confirm profit growth in the electronic materials segment (maintaining a segment profit margin above 20%) and progress toward achieving the ¥2.4 billion operating profit target.
- If signs of deficit reduction and a return to profitability (e.g., adoption by new customers) appear in the impaired cosmetic materials segment.
[Triggers to heighten caution]
- If overall operating profit falls further below ¥6.0 billion following the withdrawal from titanium dioxide.
- If the company fails to pass on surging raw material costs to product prices, leading to a noticeable deterioration in spreads outside of electronic materials.
Armed with a powerful growth engine in AI and EV materials alongside abundant cash, how will this long-established company transform into a lean, highly profitable enterprise? I intend to track the trajectory of this structural reform through the quarterly numbers.
Want to simulate the "fair value" of SAKAI CHEMICAL INDUSTRY CO., LTD.?
Interested in digging deeper into the financial data for SAKAI CHEMICAL INDUSTRY CO., LTD. featured in this article?
At okuriru.com, you can run simulations for SAKAI CHEMICAL INDUSTRY CO., LTD. based on Buffett-style "owner earnings." Enter your required rate of return (hurdle rate) to instantly calculate a theoretical stock price.
👉 Calculate SAKAI CHEMICAL INDUSTRY CO., LTD.'s theoretical stock price
Resolve the question "Is this stock fairly priced?" using your own criteria. CSV downloads of financial data are available too!